GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (FRA:9LB) » Definitions » Inventories, Other

Legend Biotech (FRA:9LB) Inventories, Other : €0.0 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Legend Biotech's other inventories for the quarter that ended in Mar. 2024 was €0.0 Mil.

Legend Biotech's quarterly other inventories increased from Sep. 2023 (€-0.0 Mil) to Dec. 2023 (€0.0 Mil) but then stayed the same from Dec. 2023 (€0.0 Mil) to Mar. 2024 (€0.0 Mil).


Legend Biotech Inventories, Other Historical Data

The historical data trend for Legend Biotech's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech Inventories, Other Chart

Legend Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Other
Get a 7-Day Free Trial - - - - -

Legend Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.37 - - - -

Legend Biotech Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


Legend Biotech (FRA:9LB) Business Description

Traded in Other Exchanges
Address
2101 Cottontail Lane, Somerset, NJ, USA, 08873
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.

Legend Biotech (FRA:9LB) Headlines

No Headlines